Habener JF - Search Results

1

Does GLP-1 suppress its own basal secretion?

Elahi D, Ruff DA, Carlson OD, Meneilly GS, Habener JF, Egan JM. Elahi D, et al. Among authors: habener jf. Endocr Res. 2016;41(1):16-20. doi: 10.3109/07435800.2015.1038353. Epub 2015 Jul 17. Endocr Res. 2016. PMID: 26186406 Free PMC article. Clinical Trial.

2

GLP-1(32-36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs.

Elahi D, Angeli FS, Vakilipour A, Carlson OD, Tomas E, Egan JM, Habener JF, Shannon RP. Elahi D, et al. Among authors: habener jf. Peptides. 2014 Sep;59:20-4. doi: 10.1016/j.peptides.2014.06.004. Epub 2014 Jun 14. Peptides. 2014. PMID: 24937653 Free PMC article.

3

Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.

Egan JM, Meneilly GS, Habener JF, Elahi D. Egan JM, et al. Among authors: habener jf. J Clin Endocrinol Metab. 2002 Aug;87(8):3768-73. doi: 10.1210/jcem.87.8.8743. J Clin Endocrinol Metab. 2002. PMID: 12161508 Clinical Trial.

4

Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.

Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Ehlers MR, Egan JM, Elahi D. Meneilly GS, et al. Among authors: habener jf. Diabetes Care. 2003 Mar;26(3):837-42. doi: 10.2337/diacare.26.3.837. Diabetes Care. 2003. PMID: 12610046 Clinical Trial.

5

Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes.

Meneilly GS, Greig N, Tildesley H, Habener JF, Egan JM, Elahi D. Meneilly GS, et al. Among authors: habener jf. Diabetes Care. 2003 Oct;26(10):2835-41. doi: 10.2337/diacare.26.10.2835. Diabetes Care. 2003. PMID: 14514588 Clinical Trial.

6

GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide.

Elahi D, Egan JM, Shannon RP, Meneilly GS, Khatri A, Habener JF, Andersen DK. Elahi D, et al. Among authors: habener jf. Obesity (Silver Spring). 2008 Jul;16(7):1501-9. doi: 10.1038/oby.2008.229. Epub 2008 Apr 17. Obesity (Silver Spring). 2008. PMID: 18421270 Free article.

7

Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene).

Clocquet AR, Egan JM, Stoffers DA, Muller DC, Wideman L, Chin GA, Clarke WL, Hanks JB, Habener JF, Elahi D. Clocquet AR, et al. Among authors: habener jf. Diabetes. 2000 Nov;49(11):1856-64. doi: 10.2337/diabetes.49.11.1856. Diabetes. 2000. PMID: 11078452

8

Effect of aging and diabetes on the enteroinsular axis.

Korosi J, McIntosh CH, Pederson RA, Demuth HU, Habener JF, Gingerich R, Egan JM, Elahi D, Meneilly GS. Korosi J, et al. Among authors: habener jf. J Gerontol A Biol Sci Med Sci. 2001 Sep;56(9):M575-9. doi: 10.1093/gerona/56.9.m575. J Gerontol A Biol Sci Med Sci. 2001. PMID: 11524451

9

Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes.

Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Gingerich R, Egan JM, Finegood DT, Elahi D. Meneilly GS, et al. Among authors: habener jf. Diabetes Care. 2001 Nov;24(11):1951-6. doi: 10.2337/diacare.24.11.1951. Diabetes Care. 2001. PMID: 11679463 Clinical Trial.

10

Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.

Meneilly GS, McIntosh CH, Pederson RA, Habener JF, Gingerich R, Egan JM, Elahi D. Meneilly GS, et al. Among authors: habener jf. J Gerontol A Biol Sci Med Sci. 2001 Nov;56(11):M681-5. doi: 10.1093/gerona/56.11.m681. J Gerontol A Biol Sci Med Sci. 2001. PMID: 11682575 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters